Have a feature idea you'd love to see implemented?
Let us know!
SHC Sotera Health Co
Price (delayed)
$12.41
Market cap
$3.51B
P/E Ratio
49.64
Dividend/share
N/A
EPS
$0.25
Enterprise value
$5.56B
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three
Highlights
SHC's net income has surged by 123% year-on-year and by 76% since the previous quarter
SHC's EPS has soared by 123% year-on-year and by 79% since the previous quarter
Key stats
What are the main financial stats of SHC
Market
Valuations
Earnings
Shares outstanding
283.24M
Market cap
$3.51B
Enterprise value
$5.56B
Price to earnings (P/E)
49.64
Price to book (P/B)
7.48
Price to sales (P/S)
3.14
EV/EBIT
18.49
EV/EBITDA
11.97
EV/Sales
4.97
Revenue
$1.12B
EBIT
$300.96M
EBITDA
$465.01M
Free cash flow
$103.54M
Per share
Balance sheet
Liquidity
EPS
$0.25
Free cash flow per share
$0.37
Book value per share
$1.66
Revenue per share
$3.96
TBVPS
$5.98
Total assets
$3.15B
Total liabilities
$2.68B
Debt
$2.36B
Equity
$470.16M
Working capital
$368.08M
Debt to equity
5.01
Current ratio
2.88
Quick ratio
2.24
Net debt/EBITDA
4.41
Margins
Efficiency
Dividend
EBITDA margin
41.5%
Gross margin
55.2%
Net margin
6.3%
Operating margin
28.1%
Return on assets
2.3%
Return on equity
16%
Return on invested capital
8.6%
Return on capital employed
10.2%
Return on sales
26.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SHC stock price
How has the Sotera Health stock price performed over time
Intraday
-6.06%
1 week
-17.21%
1 month
-20.55%
1 year
-9.08%
YTD
-26.35%
QTD
-25.69%
Financial performance
How have Sotera Health's revenue and profit performed over time
Revenue
$1.12B
Gross profit
$618.01M
Operating income
$314.5M
Net income
$70.76M
Gross margin
55.2%
Net margin
6.3%
SHC's net income has surged by 123% year-on-year and by 76% since the previous quarter
SHC's net margin has surged by 120% year-on-year and by 70% since the previous quarter
Sotera Health's operating income has increased by 35% YoY
The company's operating margin rose by 20% YoY
Growth
What is Sotera Health's growth rate over time
Valuation
What is Sotera Health stock price valuation
P/E
49.64
P/B
7.48
P/S
3.14
EV/EBIT
18.49
EV/EBITDA
11.97
EV/Sales
4.97
SHC's EPS has soared by 123% year-on-year and by 79% since the previous quarter
The price to earnings (P/E) is 36% less than the last 4 quarters average of 77.1
SHC's P/B is 31% below its 5-year quarterly average of 10.8 and 19% below its last 4 quarters average of 9.2
Sotera Health's equity has increased by 25% YoY and by 11% QoQ
SHC's P/S is 41% below its 5-year quarterly average of 5.3 and 15% below its last 4 quarters average of 3.7
SHC's revenue is up by 13% year-on-year and by 2% since the previous quarter
Efficiency
How efficient is Sotera Health business performance
Sotera Health's ROA has soared by 124% YoY and by 77% from the previous quarter
The company's return on equity has surged by 120% YoY and by 67% QoQ
The return on invested capital is up by 15% since the previous quarter
SHC's ROS is up by 14% since the previous quarter
Dividends
What is SHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SHC.
Financial health
How did Sotera Health financials performed over time
Sotera Health's total assets is 18% higher than its total liabilities
Sotera Health's quick ratio has increased by 21% YoY and by 2.3% from the previous quarter
Sotera Health's current ratio has increased by 11% YoY
Sotera Health's equity has increased by 25% YoY and by 11% QoQ
SHC's debt to equity is down by 19% year-on-year and by 10% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.